Ideal candidates include patients with acute sports injuries seeking accelerated recovery, chronic tendinopathies that have not responded to conservative management, post-surgical orthopedic cases where optimized healing is a priority, inflammatory joint conditions where traditional treatments have fallen short, and autoimmune-mediated pain where immune modulation may provide benefit
If trials confirm current findings, it may enter official approval phases in the near future
NMR relaxation analysis Data analysis von R 1 and R 1 measurements were performed using CcpNMR 2.5 49
Early studies even suggest it could have a role in addressing complex conditions like Multiple Sclerosis
GHK-Cu has shown protective effects on cartilage and bone cells in vitro, suggesting potential in joint or bone healing
Timeline: High-dose results won't be available until 2028+, well after standard-dose approval